A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Summary

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesity or overweight in pediatric participants.

Timeline

Start

2024-11-18

Primary completion

2027-02

Completion

2027-03

Drugs

Indications